Prevalence and Factors Associated With Hepatitis C Virus in Riyadh, Saudi Arabia: A Large Cross-Sectional Study.

IF 3.8 4区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Nasser Alhaydar, Raghib Abusaris, Noof Alwatban
{"title":"Prevalence and Factors Associated With Hepatitis C Virus in Riyadh, Saudi Arabia: A Large Cross-Sectional Study.","authors":"Nasser Alhaydar, Raghib Abusaris, Noof Alwatban","doi":"10.1007/s44197-025-00383-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Viral hepatitis stands accountable for approximately 1.34 million deaths worldwide, with the number of fatalities steadily growing with time. This is partly due to the various genotypes of hepatitis C virus and having no vaccination developed yet. However, a paradigm shift in the epidemiology of hepatitis C was notable due to the emergence of direct-acting antiviral drugs. Nevertheless, related literature in the Saudi context still requires further investigations to improve strategies and interventions targeting HCV in Saudi Arabia.</p><p><strong>Objectives: </strong>This study was conducted to estimate the lifetime prevalence of hepatitis C virus (HVC) in Riyadh, KSA, and assess factors associated with HCV that include demographics and co-morbidities.</p><p><strong>Methods and materials: </strong>This cross-sectional study was conducted at a tertiary healthcare facility, located in Riyadh. The patients' database was searched for data regarding hepatitis C screening and treatment in a time window from 2017 to 2022. The study sample was composed of all individuals screened for or diagnosed with hepatitis C infection in the previously mentioned settings.</p><p><strong>Results: </strong>Our sample included a total of 16,690 participants, 929 of which had positive test results (5.6%; 95% CI: 5.2-5.9%), with the rate being significantly higher in post-COVID-19 years due to a decreased number of tests performed. Positive test results were associated with male gender (43.4%), chronic kidney disease (11.8%), diabetes mellitus (34.9%), and hypertension (35%). Adjusted odds ratios (aOR) were obtained, with male gender (aOR: 2.47), widowed (aOR: 7.8) or divorced (aOR: 2.07) marital status, diabetes mellitus (aOR: 1.97), and hypertension (aOR: 2.87). Singles were found to be at lower risk of infection (aOR: 0.38). For each additional year of the study window, the odds of infection increased by 1.18.</p><p><strong>Conclusion: </strong>Between 2017 and 2022, The HCV RNA positive cases were estimated to be 5.6%. Several risk factors were identified, including male gender, being widowed or divorced, and having diabetes mellitus, and hypertension. These results underline several opportunities to improve public health efforts and clinical practice in Saudi Arabia. That will further enhance the agenda targeting the burden of HCV in the country.</p><p><strong>Clinical trial: </strong>Not applicable.</p>","PeriodicalId":15796,"journal":{"name":"Journal of Epidemiology and Global Health","volume":"15 1","pages":"42"},"PeriodicalIF":3.8000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11903971/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Epidemiology and Global Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s44197-025-00383-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Viral hepatitis stands accountable for approximately 1.34 million deaths worldwide, with the number of fatalities steadily growing with time. This is partly due to the various genotypes of hepatitis C virus and having no vaccination developed yet. However, a paradigm shift in the epidemiology of hepatitis C was notable due to the emergence of direct-acting antiviral drugs. Nevertheless, related literature in the Saudi context still requires further investigations to improve strategies and interventions targeting HCV in Saudi Arabia.

Objectives: This study was conducted to estimate the lifetime prevalence of hepatitis C virus (HVC) in Riyadh, KSA, and assess factors associated with HCV that include demographics and co-morbidities.

Methods and materials: This cross-sectional study was conducted at a tertiary healthcare facility, located in Riyadh. The patients' database was searched for data regarding hepatitis C screening and treatment in a time window from 2017 to 2022. The study sample was composed of all individuals screened for or diagnosed with hepatitis C infection in the previously mentioned settings.

Results: Our sample included a total of 16,690 participants, 929 of which had positive test results (5.6%; 95% CI: 5.2-5.9%), with the rate being significantly higher in post-COVID-19 years due to a decreased number of tests performed. Positive test results were associated with male gender (43.4%), chronic kidney disease (11.8%), diabetes mellitus (34.9%), and hypertension (35%). Adjusted odds ratios (aOR) were obtained, with male gender (aOR: 2.47), widowed (aOR: 7.8) or divorced (aOR: 2.07) marital status, diabetes mellitus (aOR: 1.97), and hypertension (aOR: 2.87). Singles were found to be at lower risk of infection (aOR: 0.38). For each additional year of the study window, the odds of infection increased by 1.18.

Conclusion: Between 2017 and 2022, The HCV RNA positive cases were estimated to be 5.6%. Several risk factors were identified, including male gender, being widowed or divorced, and having diabetes mellitus, and hypertension. These results underline several opportunities to improve public health efforts and clinical practice in Saudi Arabia. That will further enhance the agenda targeting the burden of HCV in the country.

Clinical trial: Not applicable.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.70
自引率
1.40%
发文量
57
审稿时长
19 weeks
期刊介绍: The Journal of Epidemiology and Global Health is an esteemed international publication, offering a platform for peer-reviewed articles that drive advancements in global epidemiology and international health. Our mission is to shape global health policy by showcasing cutting-edge scholarship and innovative strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信